Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Hilgartner

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
American Journal of Hematology|April 1, 1993
Loss of high-responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: a report from the Multi-Center Hemophilia Cohort StudyG L Bray, B L Kroner, S Arkin, et al.
Progress in Clinical and Biological Research|January 1, 1984
Panel discussion on the treatment of patients with factor VIII inhibitorsJ M Lusher, M E Eyster, M W Hilgartner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
HTLV-III neutralizing antibody development in transfusion-dependent seropositive patients with beta-thalassemiaM Robert-Guroff, P J Giardina, W G Robey, et al.
BMJ (Clinical Research Ed.)|January 25, 1992
Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study GroupL M Aledort, M W Hilgartner, M C Pike, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2001
Relation between HIV-1 and hepatitis C viral load in patients with hemophiliaE S Daar, H Lynn, S Donfield, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 20, 1999
High prevalence of antibodies against HERV-K10 in patients with testicular cancer but not with AIDSJ J Goedert, M E Sauter, L P Jacobson, et al.
Archives of Internal Medicine|June 1, 1989
The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experienceD B Brettler, A D Forsberg, P H Levine, et al.
Transfusion|February 1, 1992
Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator GroupP M Mannucci, K Schimpf, T Abe, et al.
Blood|August 1, 1983
Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpuraJ B Bussel, R P Kimberly, R D Inman, et al.
Blood|April 15, 1995
Blood transfusions and immunophenotypic alterations of lymphocyte subsets in sickle cell anemia. The Transfusion Safety Study GroupW Y Wong, D R Powars, E A Operskalski, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
American Journal of Hematology|April 1, 1993
Loss of high-responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: a report from the Multi-Center Hemophilia Cohort StudyG L Bray, B L Kroner, S Arkin, et al.
Progress in Clinical and Biological Research|January 1, 1984
Panel discussion on the treatment of patients with factor VIII inhibitorsJ M Lusher, M E Eyster, M W Hilgartner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
HTLV-III neutralizing antibody development in transfusion-dependent seropositive patients with beta-thalassemiaM Robert-Guroff, P J Giardina, W G Robey, et al.
BMJ (Clinical Research Ed.)|January 25, 1992
Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study GroupL M Aledort, M W Hilgartner, M C Pike, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2001
Relation between HIV-1 and hepatitis C viral load in patients with hemophiliaE S Daar, H Lynn, S Donfield, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 20, 1999
High prevalence of antibodies against HERV-K10 in patients with testicular cancer but not with AIDSJ J Goedert, M E Sauter, L P Jacobson, et al.
Archives of Internal Medicine|June 1, 1989
The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experienceD B Brettler, A D Forsberg, P H Levine, et al.
Transfusion|February 1, 1992
Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator GroupP M Mannucci, K Schimpf, T Abe, et al.
Blood|August 1, 1983
Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpuraJ B Bussel, R P Kimberly, R D Inman, et al.
Blood|April 15, 1995
Blood transfusions and immunophenotypic alterations of lymphocyte subsets in sickle cell anemia. The Transfusion Safety Study GroupW Y Wong, D R Powars, E A Operskalski, et al.
Pageof 12